InsiderPulse| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-29 | 2026-05-06 | Behrenbruch Christian | Director & MD & Group CEO | Purchase | 33.4K | $14.87 | $497K | 20.74M | View ↗ | |
| 2026-04-28 | 2026-05-06 | Behrenbruch Christian | Director & MD & Group CEO | Purchase | 34.5K | $14.48 | $500K | 20.71M | View ↗ |
No financial data available for TLX.
Company may not file with SEC or CIK is unresolved.
New Publication Demonstrates TLX250-Px (Zircaix®) Potential in Diagnosing Kidney Cancers Beyond ccRCC
William Blair updates conviction stock list
Telix Pharmaceuticals Limited (TLX) Discusses Advances in PSMA Therapy and Insights from the OPTIMAL-PSMA Trial with TLX597 - Slideshow
Insider Buying: Telix Pharmaceuticals Co-Founder Bought US$997k Of Shares